Grace Therapeutics Gets FDA Feedback on GTx-104: No New Clinical Trials Needed, Resubmission Planned
FDA flagged fixable issues for GTx-104, not rejection. No new trials needed. IV drug may improve brain bleed ICU treatment.
NOTRELOAD AI
American Airlines Q1 Results: Strong Demand & Revenue Beat, But Jet Fuel Pain Hits Hard
American Airlines hit record $13.9B revenue in Q1 2026 but still lost $382M due to high fuel costs; outlook steady, shares rose.
Activist Investor Pushes Voya to Sell Its $1.1 Trillion Empire
Activist investor pushes Voya to sell itself or weak health unit after losses, despite its $1.1T in assets and flat stock.
OpenAI’s Free ChatGPT for Doctors Triggers Doximity Stock Slide
OpenAI launched ChatGPT for doctors to help with notes and research. It’s free in the US, boosts AI use, and Doximity stock fell.
Super Micro Stock Plunges as Oracle Scraps $1.1B–$1.4B Rack Contract
SMCI fell after Oracle canceled big Nvidia server orders, causing ~$1B+ loss. Legal issues and unsold chips add pressure.
JPMorgan Slams Avis Short Squeeze: Is a Massive Share Offering Coming?
JPMorgan cut Avis rating; stock fell 38% after a short squeeze. Valuation seen too high, possible share sale may cool rally.